logo
Select company
Select metric
$ -86.04MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
9
Sector
22
Industry
32
History
67
$ 7.41Close
$ 5.8 - $ 16.39 52-Week Range
Ticker Information

Ticker

DAWN

Company Name

DAY ONE BIOPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DAY ONE BIOPHARMACEUTICALS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DAWN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 3.36M$ -89.4M$ -86.04M
3/31/2025$ 2.81M$ -61.94M$ -59.13M
12/31/2024$ 2.03M$ -88.35M$ -86.32M
9/30/2024$ 1.37M$ -83.62M$ -82.25M
6/30/2024$ 726K$ -165.93M$ -165.2M
3/31/2024$ 410K$ -208.94M$ -208.53M
12/31/2023$ 383K$ -188.92M$ -188.53M
9/30/2023$ 460K$ -177.18M$ -176.72M
6/30/2023$ 526K$ -170.72M$ -170.19M
3/31/2023$ 567K$ -161.57M$ -161M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DAY ONE BIOPHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDA stands at $ -43.66M.
  • Over the past 5 years, DAY ONE BIOPHARMACEUTICALS INC's average EBITDA has been $ -122.61M.
  • The median EBITDA for DAY ONE BIOPHARMACEUTICALS INC during this period was $ -115.55M
  • DAY ONE BIOPHARMACEUTICALS INC reached its highest EBITDA over the past 5 years at $ -43.66M.
  • The lowest EBITDA recorded by DAY ONE BIOPHARMACEUTICALS INC in the same timeframe $ -208.53M

DAY ONE BIOPHARMACEUTICALS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
STOK : STOKE THERAPEUTICS INC $ 44.92MAKBA : AKEBIA THERAPEUTICS INC $ 15.38MDNA : GINKGO BIOWORKS HOLDINGS INC $ -222.12MGERN : GERON CORP $ -58.41MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -101.19MKROS : KEROS THERAPEUTICS INC $ 30.57MNAGE : NIAGEN BIOSCIENCE INC $ 19.78MPHAT : PHATHOM PHARMACEUTICALS INC $ -256.75MANAB : ANAPTYSBIO INC $ -130.11MXNCR : XENCOR INC $ -123.36M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for DAY ONE BIOPHARMACEUTICALS INC is calculated as follows: EBIT [ $ -43.81M ] + DepAmor [ $ 155K ]
(=) EBITDA [ $ -43.66M ]

DAWN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -208.53M

Minimum

Mar 31, 2024

$ -43.66M

Maximum

Dec 31, 2020

$ -122.61M

Average

$ -115.55M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 166.93M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.76M
median$ 8.83M
std$ 166.93M